Global Spinal Muscular Atrophy Medicine Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Spinal Muscular Atrophy Medicine

• 1.1 Definition of Spinal Muscular Atrophy Medicine
• 1.2 Spinal Muscular Atrophy Medicine Segment by Type
  • 1.2.1 Global Spinal Muscular Atrophy Medicine Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 LMI-070
  • 1.2.3 ND-602
  • 1.2.4 NT-1654
  • 1.2.5 Nusinersen
  • 1.2.6 NXD-30001
  • 1.2.7 Others
• 1.3 Spinal Muscular Atrophy Medicine Segment by Applications
  • 1.3.1 Global Spinal Muscular Atrophy Medicine Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Spinal Muscular Atrophy Medicine Overall Market
  • 1.4.1 Global Spinal Muscular Atrophy Medicine Revenue (2014-2025)
  • 1.4.2 Global Spinal Muscular Atrophy Medicine Production (2014-2025)
  • 1.4.3 North America Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
  • 1.4.4 Europe Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
  • 1.4.5 China Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
  • 1.4.6 Japan Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)
  • 1.4.8 India Spinal Muscular Atrophy Medicine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Spinal Muscular Atrophy Medicine
• 2.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
• 2.4 Industry Chain Structure of Spinal Muscular Atrophy Medicine

3 Development and Manufacturing Plants Analysis of Spinal Muscular Atrophy Medicine

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Spinal Muscular Atrophy Medicine Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Spinal Muscular Atrophy Medicine
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Spinal Muscular Atrophy Medicine Production and Capacity Analysis
• 4.2 Spinal Muscular Atrophy Medicine Revenue Analysis
• 4.3 Spinal Muscular Atrophy Medicine Price Analysis
• 4.4 Market Concentration Degree

5 Spinal Muscular Atrophy Medicine Regional Market Analysis

• 5.1 Spinal Muscular Atrophy Medicine Production by Regions
  • 5.1.1 Global Spinal Muscular Atrophy Medicine Production by Regions
  • 5.1.2 Global Spinal Muscular Atrophy Medicine Revenue by Regions
• 5.2 Spinal Muscular Atrophy Medicine Consumption by Regions
• 5.3 North America Spinal Muscular Atrophy Medicine Market Analysis
  • 5.3.1 North America Spinal Muscular Atrophy Medicine Production
  • 5.3.2 North America Spinal Muscular Atrophy Medicine Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Spinal Muscular Atrophy Medicine Import and Export
• 5.4 Europe Spinal Muscular Atrophy Medicine Market Analysis
  • 5.4.1 Europe Spinal Muscular Atrophy Medicine Production
  • 5.4.2 Europe Spinal Muscular Atrophy Medicine Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Spinal Muscular Atrophy Medicine Import and Export
• 5.5 China Spinal Muscular Atrophy Medicine Market Analysis
  • 5.5.1 China Spinal Muscular Atrophy Medicine Production
  • 5.5.2 China Spinal Muscular Atrophy Medicine Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Spinal Muscular Atrophy Medicine Import and Export
• 5.6 Japan Spinal Muscular Atrophy Medicine Market Analysis
  • 5.6.1 Japan Spinal Muscular Atrophy Medicine Production
  • 5.6.2 Japan Spinal Muscular Atrophy Medicine Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Spinal Muscular Atrophy Medicine Import and Export
• 5.7 Southeast Asia Spinal Muscular Atrophy Medicine Market Analysis
  • 5.7.1 Southeast Asia Spinal Muscular Atrophy Medicine Production
  • 5.7.2 Southeast Asia Spinal Muscular Atrophy Medicine Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Spinal Muscular Atrophy Medicine Import and Export
• 5.8 India Spinal Muscular Atrophy Medicine Market Analysis
  • 5.8.1 India Spinal Muscular Atrophy Medicine Production
  • 5.8.2 India Spinal Muscular Atrophy Medicine Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Spinal Muscular Atrophy Medicine Import and Export

6 Spinal Muscular Atrophy Medicine Segment Market Analysis (by Type)

• 6.1 Global Spinal Muscular Atrophy Medicine Production by Type
• 6.2 Global Spinal Muscular Atrophy Medicine Revenue by Type
• 6.3 Spinal Muscular Atrophy Medicine Price by Type

7 Spinal Muscular Atrophy Medicine Segment Market Analysis (by Application)

• 7.1 Global Spinal Muscular Atrophy Medicine Consumption by Application
• 7.2 Global Spinal Muscular Atrophy Medicine Consumption Market Share by Application (2014-2019)

8 Spinal Muscular Atrophy Medicine Major Manufacturers Analysis

• 8.1 Astellas Pharma Inc.
  • 8.1.1 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
  • 8.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 AveXis, Inc.
  • 8.2.1 AveXis, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.2.2 AveXis, Inc. Product Introduction, Application and Specification
  • 8.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bioblast Pharma Ltd.
  • 8.3.1 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.3.2 Bioblast Pharma Ltd. Product Introduction, Application and Specification
  • 8.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Cytokinetics, Inc. 24
  • 8.4.1 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.4.2 Cytokinetics, Inc. 24 Product Introduction, Application and Specification
  • 8.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 F. Hoffmann-La Roche Ltd.
  • 8.5.1 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.5.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
  • 8.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Genethon
  • 8.6.1 Genethon Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.6.2 Genethon Product Introduction, Application and Specification
  • 8.6.3 Genethon Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Genzyme Corporation
  • 8.7.1 Genzyme Corporation Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.7.2 Genzyme Corporation Product Introduction, Application and Specification
  • 8.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 GMP-Orphan SAS
  • 8.8.1 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.8.2 GMP-Orphan SAS Product Introduction, Application and Specification
  • 8.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Ionis Pharmaceuticals, Inc.
  • 8.9.1 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.9.2 Ionis Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Longevity Biotech, Inc
  • 8.10.1 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production Sites and Area Served
  • 8.10.2 Longevity Biotech, Inc Product Introduction, Application and Specification
  • 8.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Neurodyn Inc.
• 8.12 Neurotune AG
• 8.13 Novartis AG
• 8.14 Sarepta Therapeutics, Inc.
• 8.15 Voyager Therapeutics, Inc.
• 8.16 Vybion, Inc.
• 8.17 WAVE Life Sciences Ltd.

9 Development Trend of Analysis of Spinal Muscular Atrophy Medicine Market

• 9.1 Global Spinal Muscular Atrophy Medicine Market Trend Analysis
  • 9.1.1 Global Spinal Muscular Atrophy Medicine Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Spinal Muscular Atrophy Medicine Regional Market Trend
  • 9.2.1 North America Spinal Muscular Atrophy Medicine Forecast 2019-2025
  • 9.2.2 Europe Spinal Muscular Atrophy Medicine Forecast 2019-2025
  • 9.2.3 China Spinal Muscular Atrophy Medicine Forecast 2019-2025
  • 9.2.4 Japan Spinal Muscular Atrophy Medicine Forecast 2019-2025
  • 9.2.5 Southeast Asia Spinal Muscular Atrophy Medicine Forecast 2019-2025
  • 9.2.6 India Spinal Muscular Atrophy Medicine Forecast 2019-2025
• 9.3 Spinal Muscular Atrophy Medicine Market Trend (Product Type)
• 9.4 Spinal Muscular Atrophy Medicine Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Spinal Muscular Atrophy Medicine Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List